RAMELTEON (Rozerem) Nursing Considerations

What is the generic name?

RAMELTEON

What is the Trade Name for RAMELTEON?

Rozerem

What are the Indications for RAMELTEON?

• 1 INDICATIONS AND USAGE ROZEREM is indicated for the treatment of insomnia characterized by difficulty with sleep onset. The clinical trials performed in support of efficacy were up to six months in duration. The final formal assessments of sleep latency were performed after two days of treatment during the crossover study (elderly only), at five weeks in the six week studies (adults and elderly), and at the end of the six month study (adults and elderly) [see Clinical Studies (14) ] . ROZEREM is indicated for the treatment of insomnia characterized by difficulty with sleep onset. ( 1 )

References: https://open.fda.gov/